These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 2004621

  • 1. Noradrenergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats.
    Dailey JW, Mishra PK, Ko KH, Penny JE, Jobe PC.
    Epilepsia; 1991; 32(2):168-73. PubMed ID: 2004621
    [Abstract] [Full Text] [Related]

  • 2. Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats.
    Dailey JW, Mishra PK, Ko KH, Penny JE, Jobe PC.
    Life Sci; 1992; 50(4):319-26. PubMed ID: 1732702
    [Abstract] [Full Text] [Related]

  • 3. Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy-prone rats (GEPR-9s).
    Mishra PK, Kahle EH, Bettendorf AF, Dailey JW, Jobe PC.
    Life Sci; 1993; 52(17):1435-41. PubMed ID: 8464344
    [Abstract] [Full Text] [Related]

  • 4. Indices of noradrenergic function in the central nervous system of seizure-naive genetically epilepsy-prone rats.
    Dailey JW, Jobe PC.
    Epilepsia; 1986; 27(6):665-70. PubMed ID: 2877867
    [Abstract] [Full Text] [Related]

  • 5. Roles of neurotransmitter amino acids in seizure severity and experience in the genetically epilepsy-prone rat.
    Lasley SM.
    Brain Res; 1991 Sep 27; 560(1-2):63-70. PubMed ID: 1684733
    [Abstract] [Full Text] [Related]

  • 6. Neurite extension of developing noradrenergic neurons is impaired in genetically epilepsy-prone rats (GEPR-3s): an in vitro study on the locus coeruleus.
    Clough RW, Peterson BR, Steenbergen JL, Jobe PC, Eells JB, Browning RA, Mishra PK.
    Epilepsy Res; 1998 Jan 27; 29(2):135-46. PubMed ID: 9477146
    [Abstract] [Full Text] [Related]

  • 7. Abnormalities in monoamine levels in the central nervous system of the genetically epilepsy-prone rat.
    Jobe PC, Laird HE, Ko KH, Ray T, Dailey JW.
    Epilepsia; 1982 Aug 27; 23(4):359-66. PubMed ID: 6284498
    [Abstract] [Full Text] [Related]

  • 8. Brainstem seizure severity regulates forebrain seizure expression in the audiogenic kindling model.
    Merrill MA, Clough RW, Jobe PC, Browning RA.
    Epilepsia; 2005 Sep 27; 46(9):1380-8. PubMed ID: 16146432
    [Abstract] [Full Text] [Related]

  • 9. Effect of norepinephrine release on adrenoceptors in severe seizure genetically epilepsy-prone rats.
    Seo DO, Shin CY, Ryu JR, Cheong JH, Choi CR, Dailey JW, Reith ME, Jobe PC, Ko KH.
    Eur J Pharmacol; 2000 May 19; 396(2-3):53-8. PubMed ID: 10822056
    [Abstract] [Full Text] [Related]

  • 10. Neurobiology of seizure predisposition in the genetically epilepsy-prone rat.
    Dailey JW, Reigel CE, Mishra PK, Jobe PC.
    Epilepsy Res; 1989 May 19; 3(1):3-17. PubMed ID: 2563686
    [Abstract] [Full Text] [Related]

  • 11. Noradrenergic and serotonergic determinants of seizure susceptibility and severity in genetically epilepsy-prone rats.
    Jobe PC, Dailey JW, Reigel CE.
    Life Sci; 1986 Sep 01; 39(9):775-82. PubMed ID: 3747729
    [Abstract] [Full Text] [Related]

  • 12. The genetically epilepsy-prone rat (GEPR).
    Jobe PC, Mishra PK, Adams-Curtis LE, Deoskar VU, Ko KH, Browning RA, Dailey JW.
    Ital J Neurol Sci; 1995 Sep 01; 16(1-2):91-9. PubMed ID: 7642359
    [Abstract] [Full Text] [Related]

  • 13. Noradrenergic abnormalities in the genetically epilepsy-prone rat.
    Jobe PC, Mishra PK, Browning RA, Wang C, Adams-Curtis LE, Ko KH, Dailey JW.
    Brain Res Bull; 1994 Sep 01; 35(5-6):493-504. PubMed ID: 7859107
    [Abstract] [Full Text] [Related]

  • 14. Alterations in brain and pituitary beta-endorphin content in genetically epilepsy-prone rats.
    Carr JA, Carpenter AM, D'Souza MM, Elmore AR, Lovering AT, Reigel CE.
    Epilepsy Res; 1998 Jul 01; 31(2):113-22. PubMed ID: 9714502
    [Abstract] [Full Text] [Related]

  • 15. Brain norepinephrine and convulsions in the genetically epilepsy-prone rat: sex-dependent responses to Ro 4-1284 treatment.
    Mishra PK, Dailey JW, Reigel CE, Jobe PC.
    Life Sci; 1988 Jul 01; 42(11):1131-7. PubMed ID: 3347143
    [Abstract] [Full Text] [Related]

  • 16. Effects of intraventricular locus coeruleus transplants on seizure severity in genetically epilepsy-prone rats following depletion of brain norepinephrine.
    Clough RW, Browning RA, Maring ML, Statnick MA, Wang C, Jobe PC.
    J Neural Transplant Plast; 1994 Jul 01; 5(1):65-79. PubMed ID: 7819373
    [Abstract] [Full Text] [Related]

  • 17. Glutamatergic activation of the amygdala differentially mimics the effects of audiogenic seizure kindling in two substrains of genetically epilepsy-prone rats.
    Raisinghani M, Feng HJ, Faingold CL.
    Exp Neurol; 2003 Oct 01; 183(2):516-22. PubMed ID: 14552892
    [Abstract] [Full Text] [Related]

  • 18. The genetically epilepsy-prone rat: an overview of seizure-prone characteristics and responsiveness to anticonvulsant drugs.
    Reigel CE, Dailey JW, Jobe PC.
    Life Sci; 1986 Sep 01; 39(9):763-74. PubMed ID: 3747727
    [Abstract] [Full Text] [Related]

  • 19. Effects of age on seizure susceptibility in genetically epilepsy-prone rats (GEPR-9s).
    Thompson JL, Carl FG, Holmes GL.
    Epilepsia; 1991 Sep 01; 32(2):161-7. PubMed ID: 2004620
    [Abstract] [Full Text] [Related]

  • 20. Noradrenergic terminal fields as determinants of seizure predisposition in GEPR-3s: a neuroanatomic assessment with intracerebral microinjections of 6-hydroxydopamine.
    Wang C, Mishra PK, Dailey JW, Jobe PC, Browning RA.
    Epilepsy Res; 1994 May 01; 18(1):1-9. PubMed ID: 8088252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.